|
|
|
Opt-in for Free Newsletter, special discount
offers, drugs information & latest pharmacy news.
|
 |
|
FDA To Observe How People Respond To Drug Ads after Study Reveals Slipups
Wed, 22 August 2007
A week after a study released in the New England Journal of Medicine revealed that the FDA’s drug-ad enforcement has progressively declined, Federal regulators declares they want to make out whether soothing and upbeat drugs’ images depicted in T.V. ads divert consumers from the warnings pertaining to possible drugs' side effects.
The FDA plans to examine how people respond to the drug- ads as to verify whether consumers still uphold an affirmative image of products regardless of the audio warnings concerning potential adverse effects.
The study articulated that the FDA sent only 21 citations to drug manufacturers last year for tribulations related to consumer-pointed ads compared to 142 in 1997. Drug manufacturers are legitimately needed to depict an unbiased picture of a drug's benefits and its possible side effects in endorsements. But antagonists allege that the images of happy and unperturbed couples featured in T.V. ads outshine the audio warnings concerning the possible impediments.
Eli Lilly's ad for its impotence drug Cialis represents a middle-aged couple returning back from a shopping trip whilst soft jazz plays in the backdrop. Just before the ad's end, a male voice enumerates common side effects, including back pain, headache and muscle aches.
"If advertisers were actually concerned about the dissemination of the information about drug’s side effects, they would represent pictures of those disorders, but this is found absolutely absent in T.V. drug ads," alleged Dr. Sidney Wolfe of the advocacy group Public Citizen.
In addition to the evaluation of images’ effect over consumers, the agency will also examine how text on the screen can distract consumer’s attention from audio warnings. FDA states text steering viewers to company’s web site or magazine ads can divert viewers from crucial audio warning regarding the side effects. While on the other hand, FDA averred that the recurrence of language about possible risks in text format might assist in reinforcement of warnings.
|